Find Grants for Municipalities, Political Subdivisions, and State Governments
Find out if you qualify for verified grants for Municipalities, Political Subdivisions, and State Governments . Discover your eligibility and key funding details for Municipalities, Political Subdivisions, and State Governments from major foundations and government agencies.
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-330
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-100
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.279
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Deadline: June 2, 2026
Opportunity Number: RFA-TR-25-002
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: June 2, 2026
Status: Posted
CFDA Numbers: 93.350
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-055
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Deadline: December 3, 2027
Opportunity Number: RFA-DA-26-056
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: December 3, 2027
Status: Posted
CFDA Numbers: 93.273, 93.279
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-299
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.273, 93.307, 93.399
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-025
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.233, 93.837
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-026
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.840, 93.233, 93.839, 93.837, 93.838
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Deadline: May 7, 2026
Opportunity Number: PAR-25-239
Agency: National Institutes of Health
Open Date: December 5, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.121
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: November 5, 2027
Opportunity Number: PAR-25-297
Agency: National Institutes of Health
Open Date: December 4, 2024
Close Date: November 5, 2027
Status: Posted
CFDA Numbers: 93.866
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-310
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.242
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-251
Agency: National Institutes of Health
Open Date: December 3, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.855
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-215
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Deadline: November 12, 2027
Opportunity Number: PAR-25-216
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-265
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-266
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-270
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-269
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-271
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-188
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Alcohol Health Services Research (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PA-25-245
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Health Services Research (R34 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-192
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
Deadline: September 7, 2026
Opportunity Number: PA-25-163
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
Deadline: September 7, 2026
Opportunity Number: PAR-25-193
Agency: National Institutes of Health
Open Date: November 27, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.273
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-179
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242